Chemed Corporation Stock price

Equities

CHE

US16359R1032

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
641.9 USD -0.36% Intraday chart for Chemed Corporation -0.31% +9.78%
Sales 2024 * 2.42B Sales 2025 * 2.57B Capitalization 9.7B
Net income 2024 * 322M Net income 2025 * 354M EV / Sales 2024 * 4 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 3.77 x
P/E ratio 2024 *
30.4 x
P/E ratio 2025 *
27.4 x
Employees 15,087
Yield 2024 *
0.25%
Yield 2025 *
0.25%
Free-Float 39.53%
More Fundamentals * Assessed data
Dynamic Chart
Chemed Insider Sold Shares Worth $1,704,321, According to a Recent SEC Filing MT
Chemed Insider Sold Shares Worth $7,196,910, According to a Recent SEC Filing MT
Transcript : Chemed Corporation Presents at Oppenheimer 34th Annual Healthcare MedTech & Services Conference 2024, Mar-12-2024 12:00 PM
RBC Boosts Price Target on Chemed to $712 From $604, Expects 'Strong' VITAS Momentum to Continue in 2024; Outperform Kept MT
Oppenheimer Raises Chemed Price Target to $650 From $625, Maintains Outperform Rating MT
Transcript : Chemed Corporation, Q4 2023 Earnings Call, Feb 28, 2024
Chemed Q4 Adjusted Earnings, Revenue Rise; Sets 2024 Outlook MT
Tranche Update on Chemed Corporation's Equity Buyback Plan announced on February 22, 2011. CI
Earnings Flash (CHE) CHEMED CORPORATION Reports Q4 EPS $6.60 MT
Earnings Flash (CHE) CHEMED CORPORATION Posts Q4 Revenue $350M MT
Chemed Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Chemed Maintains Quarterly Dividend at $0.40 Per Share, Payable March 15 to Shareholders of Record on Feb. 26 MT
Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024 CI
Oppenheimer Adjusts Chemed Price Target to $625 From $590, Maintains Outperform Rating MT
Transcript : Chemed Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:00 PM
More news
1 day-0.36%
1 week-0.31%
Current month+2.52%
1 month+2.08%
3 months+9.86%
6 months+22.98%
Current year+9.78%
More quotes
1 week
634.89
Extreme 634.885
648.29
1 month
605.00
Extreme 605
654.62
Current year
564.10
Extreme 564.1
654.62
1 year
492.84
Extreme 492.84
654.62
3 years
403.00
Extreme 403
654.62
5 years
313.49
Extreme 313.49
654.62
10 years
80.94
Extreme 80.94
654.62
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 85-12-31
Director of Finance/CFO 52 04-12-31
Chief Administrative Officer - 94-10-31
Members of the board TitleAgeSince
Director/Board Member 74 09-04-30
Director/Board Member 73 84-12-31
Director/Board Member 80 08-04-30
More insiders
Date Price Change Volume
24-03-28 641.9 -0.36% 53,467
24-03-27 644.3 +0.98% 62,225
24-03-26 638 -1.05% 69,680
24-03-25 644.8 -0.60% 50,391
24-03-22 648.7 +0.75% 79,834

Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT

More quotes
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
641.9 USD
Average target price
690 USD
Spread / Average Target
+7.49%
Consensus
  1. Stock
  2. Equities
  3. Stock Chemed Corporation - Nyse